Switching from one long-acting insulin to another can be confusing, especially when insulin units, concentrations, dosing schedules, and individual glucose targets all need to be considered. The Lantus to Tresiba Conversion Calculator is designed to provide an educational estimate of the Tresiba dose corresponding to a person’s current daily Lantus dose.
Lantus To Tresiba Conversion Calculator
What Is Lantus?
Lantus is a brand name for insulin glargine U-100, a long-acting basal insulin used to improve blood glucose control in people with diabetes. Lantus provides relatively continuous glucose-lowering activity and is commonly used as part of a basal-bolus or other insulin treatment plan. Its dose is individualized according to clinical response.
Because insulin needs differ substantially from one person to another, a person's current Lantus dose is only one part of the clinical picture. A conversion calculator can help explain the arithmetic involved in a potential switch, but it cannot determine whether a switch is appropriate or whether the resulting dose is correct for an individual.
What Is Tresiba?
Tresiba is the brand name for insulin degludec, another long-acting basal insulin. It is available in different concentrations, including U-100 and U-200. Current prescribing information states that Tresiba is administered once daily and that, for adults already taking insulin, it may be started at the same unit dose as the current basal insulin when switching, with subsequent individualization and titration based on glucose results and clinical needs.
The two Tresiba concentrations can look confusing because U-200 contains twice as many insulin units per milliliter as U-100. Importantly, the number of insulin units does not need to be doubled or halved when using the Tresiba FlexTouch pens. The dose window displays the units to be delivered, so the concentration does not change the number of units prescribed.
What Does the Lantus to Tresiba Conversion Calculator Do?
The calculator uses a straightforward educational conversion for a specific situation:
- An adult is switching from once-daily Lantus.
- The conversion is expressed in units per day.
- The estimated Tresiba dose uses a 1:1 unit conversion.
- The user can select Tresiba U-100 or U-200.
- If twice-daily Lantus is selected, the calculator does not provide a Tresiba dose and instead displays a warning that individualized professional guidance is needed.
This is an important distinction. The calculator is not intended to replace an individualized insulin prescription. Its primary purpose is to show the basic arithmetic involved in a commonly used adult basal-insulin switching approach.
Lantus to Tresiba Conversion Ratio
For the adult once-daily conversion represented by this calculator, the ratio is:
Lantus : Tresiba = 1 : 1
In other words, the estimated Tresiba dose in units per day is numerically equal to the entered Lantus dose in units per day.
Basic Formula
Estimated Tresiba Dose = Lantus Daily Dose × 1
Or simply:
Estimated Tresiba Dose = Lantus Daily Dose
For example, if a person enters 28 units/day of Lantus, the calculator produces an educational estimate of 28 units/day of Tresiba.
This does not mean that every person switching insulin should independently make that change. Official Tresiba information states that adult patients already taking basal insulin can start at the same unit dose when switching, but dosing should then be individualized according to blood glucose monitoring, glycemic goals, metabolic needs, and other clinical factors.
Why Is the Conversion 1:1?
Insulin doses are commonly discussed in units, which represent the amount of insulin activity delivered rather than simply the volume of liquid in the syringe or pen.
For adults switching from a long-acting basal insulin to Tresiba, current manufacturer dosing guidance and prescribing information describe a same-unit starting approach. That means a patient taking a certain number of units of another basal insulin may be started on the same number of Tresiba units, subject to clinical judgment and subsequent titration.
This is why the calculator does not perform a multiplication such as 2× or 0.5× simply because Tresiba U-200 is more concentrated than U-100.
The concentration affects volume, not the number of insulin units displayed for dosing when using the appropriate Tresiba pen.
Tresiba U-100 vs. U-200
One of the most important concepts when using this calculator is understanding the difference between Tresiba U-100 and Tresiba U-200.
| Tresiba Form | Concentration | Key Point |
|---|---|---|
| Tresiba U-100 | 100 units/mL | Standard concentration |
| Tresiba U-200 | 200 units/mL | Twice the concentration of U-100 |
| U-100 FlexTouch | 1 unit increments | Dose window displays units delivered |
| U-200 FlexTouch | 2 unit increments | Dose window displays units delivered |
Tresiba U-100 contains 100 units per milliliter, while Tresiba U-200 contains 200 units per milliliter. The U-200 formulation therefore delivers the same number of units in half the volume compared with U-100. The prescribing information specifically states that dose conversion is not required when using Tresiba U-100 or U-200 FlexTouch pens because the dose window indicates the number of insulin units being delivered.
Example of Concentration and Volume
Suppose the prescribed dose were 40 units.
With a U-100 formulation:
40 units ÷ 100 units/mL = 0.40 mL
With a U-200 formulation:
40 units ÷ 200 units/mL = 0.20 mL
The unit dose remains 40 units. The difference is the amount of liquid required to deliver those units.
This distinction is particularly important because treating U-200 as though it were U-100 can create serious dosing errors. The Tresiba prescribing information explicitly instructs users not to perform dose conversion when using the FlexTouch pens.
How to Use the Lantus to Tresiba Conversion Calculator
Using the calculator is straightforward.
Step 1: Enter the Lantus Daily Dose
Enter your current Lantus daily dose in units/day.
For example:
30 units/day
The calculator accepts positive numbers, including decimal values.
Step 2: Select the Lantus Dosing Frequency
Choose either:
- Once daily
- Twice daily
The calculator is specifically designed to calculate the educational conversion for once-daily Lantus.
If twice-daily Lantus is selected, the tool displays a warning rather than producing a conversion result. This is intentional because switching from a divided basal-insulin regimen requires individualized clinical assessment.
Step 3: Select the Tresiba Concentration
Choose:
Tresiba U-100 or Tresiba U-200
The concentration choice does not change the calculator's 1:1 unit result. It simply identifies the Tresiba concentration associated with the displayed estimate.
Step 4: Select Calculate
After entering valid information and choosing once-daily Lantus, select Calculate.
The result displays:
- Entered Lantus dose
- Estimated Tresiba dose
- Conversion ratio
- Tresiba concentration
The calculator also displays an educational disclaimer reminding users that insulin changes should be made under professional guidance.
Step 5: Review the Result Carefully
Treat the displayed number as an educational estimate, not as an instruction to change insulin therapy.
A healthcare professional may choose a different treatment plan based on the person's glucose patterns, diabetes type, current therapy, medical history, risk of hypoglycemia, or other considerations.
Lantus to Tresiba Conversion Examples
Example 1: 20 Units of Once-Daily Lantus
Suppose an adult currently takes:
20 units/day of Lantus once daily
Using the calculator's 1:1 educational conversion:
Tresiba = 20 × 1
Estimated Tresiba dose = 20 units/day
The result would be the same unit number whether the selected Tresiba concentration is U-100 or U-200.
Example 2: 35 Units of Once-Daily Lantus
Suppose the entered dose is:
35 units/day
The calculation is:
35 × 1 = 35 units/day
The educational result is therefore:
35 units/day of Tresiba
Again, this is a mathematical estimate based on the calculator's conversion rule, not an individualized prescription.
Example 3: 42.5 Units of Lantus
If the entered dose is:
42.5 units/day
Then:
42.5 × 1 = 42.5 units/day
The calculator can display decimal insulin doses when appropriate.
Actual administration must follow the specific dosing increments and delivery device prescribed by the healthcare professional. Tresiba U-100 and U-200 FlexTouch pens have different dose increments, which is another reason the device and prescribed dose should be confirmed before administration.
What Happens With Twice-Daily Lantus?
The calculator deliberately does not produce a 1:1 Tresiba estimate for twice-daily Lantus.
This is one of the most important limitations of the tool.
A once-daily basal insulin conversion cannot automatically be assumed to apply in exactly the same way to a twice-daily regimen. The reason is that a divided-dose schedule may reflect a person's individual glucose pattern, insulin requirements, timing needs, or prior treatment decisions.
The calculator therefore displays a warning advising that an individualized conversion should be determined by a healthcare professional.
This conservative approach is appropriate because insulin regimen changes can alter glycemic control and can increase the risk of hypoglycemia or hyperglycemia. Lantus prescribing information emphasizes that changes in insulin regimen should be made under medical supervision with suitable glucose monitoring.
Important Difference Between Units and Milliliters
A common mistake in insulin calculations is confusing units with milliliters (mL).
For example:
Units describe the amount of insulin being delivered.
mL describes the volume of liquid.
Different insulin concentrations can contain different numbers of units in each milliliter. This is exactly why U-100 and U-200 Tresiba cannot be compared simply by volume.
For Tresiba FlexTouch pens, the dose display is designed to show insulin units, and the prescribing information says no dose conversion is needed between the U-100 and U-200 pen concentrations.
For this reason, the calculator focuses on units/day, rather than trying to turn the result into a syringe or injection volume.
Factors That Can Affect Insulin Requirements
Even when the arithmetic of a conversion is simple, the appropriate insulin dose may not be simple.
Tresiba prescribing information notes that dose adjustments may be needed when there are changes in physical activity, meal patterns, kidney or liver function, or acute illness. It also recommends individualizing and titrating the dose based on metabolic needs, glucose monitoring, and glycemic-control goals.
Other factors that may be clinically relevant include:
| Factor | Why It Matters |
|---|---|
| Blood glucose patterns | May indicate that the basal dose needs adjustment |
| Hypoglycemia history | Can affect the safety of an insulin change |
| Diabetes type | Type 1 and type 2 diabetes have different treatment considerations |
| Food intake | Changes in meals can influence glucose requirements |
| Physical activity | Activity can alter insulin sensitivity |
| Illness | Acute illness can affect glucose levels and insulin needs |
| Kidney function | Changes may alter insulin requirements |
| Liver function | May influence glucose regulation and insulin metabolism |
| Other medications | Some medications can affect glucose control |
| Timing and adherence | Consistent administration is important for stable control |
A calculator cannot account for all these factors. That is why its result should be considered educational rather than definitive.
Why Glucose Monitoring Matters During a Switch
Changing insulin type, dose, concentration, or administration routine can affect glucose control. Official Tresiba prescribing information recommends increasing the frequency of blood glucose monitoring during changes to an insulin regimen.
The goal is not simply to calculate a number but to ensure that the person's actual glucose response remains safe and appropriate.
Both hypoglycemia and hyperglycemia can occur when insulin therapy changes. Symptoms, glucose readings, medication changes, meal patterns, and other factors should be considered in the overall clinical plan.
A healthcare professional may recommend a specific monitoring schedule during a transition.
Who Should Use This Calculator?
The calculator is most useful as an educational reference for understanding the basic adult once-daily Lantus-to-Tresiba unit relationship.
It may be useful for:
- Patients learning how basal-insulin conversions are expressed in units
- Caregivers who want to understand insulin terminology
- Students studying insulin dosing concepts
- Health-information readers researching Lantus and Tresiba
- People preparing questions to discuss with their healthcare professional
It should not be used as an independent prescription tool or as a reason to change insulin treatment without professional guidance.
Who Should Be Especially Careful?
Extra caution is appropriate for anyone who:
- Uses Lantus more than once per day
- Has frequent or severe low blood glucose episodes
- Is currently ill
- Has significant kidney or liver impairment
- Has changing dietary or activity patterns
- Uses multiple types of insulin
- Is a child or adolescent
- Is unsure which insulin concentration or device is being used
The calculator is specifically limited to the adult once-daily situation. Tresiba labeling also contains different considerations for pediatric patients, so an adult 1:1 conversion should not simply be applied to children.
Benefits of Using a Conversion Calculator
A calculator can make insulin mathematics easier to understand.
Reduces Arithmetic Errors
A simple automated calculation reduces the chance of manually multiplying or copying the wrong number.
Clearly Shows the 1:1 Ratio
The calculator reinforces that the educational adult conversion is based on the same number of insulin units.
Separates Concentration From Dose
Selecting U-100 or U-200 helps users recognize that concentration does not automatically mean the unit dose must be changed.
Highlights Unsupported Scenarios
The twice-daily Lantus warning prevents the tool from presenting an overly simplified conversion in a situation where professional assessment is needed.
Provides a Useful Starting Point for Discussion
Rather than relying on memory or informal calculations, users can use the result as a discussion point when speaking with their healthcare professional.
Limitations of the Lantus to Tresiba Conversion Calculator
No online calculator can replace individualized clinical judgment.
This tool has several important limitations:
- It does not determine the correct insulin regimen for an individual patient.
- It does not analyze glucose readings or continuous glucose monitoring data.
- It does not account for all medical conditions or medications.
- It does not provide a conversion for twice-daily Lantus.
- It does not determine insulin dose adjustments after the switch.
- It does not replace professional assessment or prescribing.
- It is intended for the educational adult once-daily basal-insulin scenario represented by the calculator.
The calculator's result should therefore be viewed as a reference estimate, not a medical order.
Frequently Asked Questions
1. What is the Lantus to Tresiba conversion ratio?
For the adult once-daily basal-insulin conversion represented by this calculator, the ratio is 1:1. That means the estimated Tresiba dose in units is numerically the same as the entered Lantus dose. Official Tresiba guidance supports a same-unit starting approach for adults switching from another basal insulin, followed by individualized treatment.
2. Is 30 units of Lantus equal to 30 units of Tresiba?
The calculator's educational formula would produce 30 units/day of Tresiba from 30 units/day of once-daily Lantus. However, the result is not a personal prescription. A healthcare professional should determine and supervise any actual insulin change.
3. Does Tresiba U-200 require half the insulin dose?
No. U-200 does not mean half as many insulin units should be prescribed. It means there are twice as many units per milliliter. For the Tresiba FlexTouch pen, the dose window indicates the number of units to be delivered, and the prescribing information says no dose conversion is needed between the U-100 and U-200 pens.
4. What is the difference between Tresiba U-100 and U-200?
Tresiba U-100 contains 100 units/mL, while Tresiba U-200 contains 200 units/mL. U-200 therefore delivers the same number of units in a smaller volume.
5. Can I use this calculator for twice-daily Lantus?
No. The calculator is intentionally limited to once-daily Lantus conversions. When twice-daily Lantus is selected, it displays a warning instead of estimating the dose.
6. Why doesn't the calculator calculate a twice-daily Lantus conversion?
Because a divided basal-insulin regimen may require individualized assessment rather than a simple automatic 1:1 calculation. The safest approach is to have the conversion determined by the healthcare professional managing the person's diabetes.
7. Is this calculator a substitute for a doctor's prescription?
No. It is an educational calculator. Actual insulin changes should be made under the direction of a qualified healthcare professional.
8. Does Lantus use the same units as Tresiba?
Both are dosed in insulin units, but they are different insulin products with different pharmacologic properties and formulations. A numerical unit relationship does not mean the products are identical.
9. Can children use the 1:1 adult conversion in this calculator?
The calculator is intended for the adult once-daily scenario. Pediatric Tresiba dosing has separate considerations, so the adult calculator should not be used to independently determine a child's dose.
10. Does the calculator account for blood glucose levels?
No. It only uses the entered Lantus dose, dosing frequency, and selected Tresiba concentration. It does not analyze glucose readings.
11. Can illness change the Tresiba dose I need?
It can. Tresiba prescribing information notes that dose adjustments may be required during acute illness and when there are changes in factors such as physical activity, meals, kidney function, or liver function.
12. Does U-200 mean the injection is stronger?
U-200 has a higher concentration—200 units per milliliter compared with 100 units per milliliter for U-100. This means more units are contained in the same volume, not that the prescribed unit number should automatically be changed.
13. Why does the calculator show a 1:1 ratio?
The calculator follows the adult basal-insulin switching approach in current Tresiba guidance, where adults already using insulin can start Tresiba at the same unit dose as their current basal insulin.
14. How soon should Tresiba be adjusted after switching?
Dose adjustment is individualized. Current Tresiba prescribing information recommends individualization and titration based on metabolic needs, glucose monitoring, and glycemic goals; it also specifies recommended intervals between dose increases.
15. What should I do before switching from Lantus to Tresiba?
Discuss the switch with your healthcare professional. Confirm the insulin type, current dose, dosing schedule, concentration, delivery device, and glucose-monitoring plan. Do not independently change insulin based only on an online calculator.
Final Thoughts
The Lantus to Tresiba Conversion Calculator provides a simple way to understand an important insulin-conversion concept: for adults already using a long-acting basal insulin, current Tresiba guidance supports a same-unit starting approach, making the educational conversion from once-daily Lantus 1:1 in units.
For example, 25 units/day of once-daily Lantus produces an educational estimate of 25 units/day of Tresiba. The selected Tresiba concentration—U-100 or U-200—does not change the number of units in the calculator result.
At the same time, insulin conversion should never be reduced to arithmetic alone. The twice-daily Lantus situation requires individualized assessment, and factors such as glucose control, hypoglycemia risk, illness, activity, food intake, kidney function, liver function, and other medications can affect insulin requirements.
Use this calculator as an educational reference to understand the unit relationship and to prepare informed questions for your healthcare professional. Any actual change from Lantus to Tresiba should be made according to an individualized medical plan, with appropriate glucose monitoring and follow-up.